Endoscopic, Histologic, and Composite Endpoints in Patients With Ulcerative Colitis Treated With Etrasimod
-
Published:2024-07
Issue:
Volume:
Page:
-
ISSN:1542-3565
-
Container-title:Clinical Gastroenterology and Hepatology
-
language:en
-
Short-container-title:Clinical Gastroenterology and Hepatology
Author:
Magro Fernando,
Peyrin-Biroulet Laurent,
Sands Bruce E.,
Danese Silvio,
Jairath Vipul,
Goetsch Martina,
Bhattacharjee Abhishek,
Wu Joseph,
Branquinho DiogoORCID,
Modesto Irene,
Feagan Brian G.
Reference23 articles.
1. Ulcerative colitis;Ungaro;Lancet,2017
2. ACG clinical guideline: ulcerative colitis in adults;Rubin;Am J Gastroenterol,2019
3. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
4. The emerging role of histologic disease activity assessment in ulcerative colitis;Pai;Gastrointest Endosc,2018
5. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders;Magro;J Crohns Colitis,2017